SEC Investigates Guggenheim Amid Asset Scrutiny

Regulators have requested interviews with staff as the firm navigates investigations into insurance portfolio accounting.

Updated on Sept. 18, 2026 in Public Companies

Bold flat-color editorial illustration of a brass balance scale atop a heavy stone block, representing regulatory scrutiny.
The SEC has opened an investigation into Guggenheim Investments regarding the firm's asset classification practices and disclosure of insurance company loans. AI Illustration. Upload story photo >

Live Poll

Do you trust that financial regulators are effectively overseeing the business practices of large investment firms?

The SEC has initiated requests to interview Guggenheim Investments employees as part of a broader regulatory investigation into the firm's accounting and asset classification practices. The scrutiny follows reports that $20 billion in insurance company loans were not properly disclosed as affiliated transactions.

Why it matters

The investigation highlights heightened regulatory focus on fee disclosure transparency and the handling of insurance company asset portfolios. For operators, the case underscores the critical need for rigorous internal controls regarding affiliated transaction labeling and regulatory compliance.

Regulators have identified $20 billion in loans improperly labeled as non-affiliated transactions. Amid the ongoing scrutiny, CEO Mark Walter has moved to divest assets, agreeing to sell a stake in the Los Angeles Lakers for $12.5 billion, up from his $10 billion acquisition cost last year.

The players

Guggenheim Investments

A global investment and advisory firm managing diversified portfolios for institutional and retail clients.

Mark Walter

The CEO of Guggenheim Investments who oversees a broad empire of financial services and sports franchise holdings.

Delaware Life Insurance Co.

An insurance provider currently under scrutiny by the Manhattan District Attorney regarding its asset management disclosures.

Clear Spring Life and Annuity Co.

An insurance entity receiving subpoenas from the Manhattan District Attorney in a joint investigation into financial reporting.

The details

The SEC investigation focuses on how Guggenheim classifies asset portfolios and discloses revenue fees, an issue previously flagged in a whistleblower report. Parallel to federal efforts, the Manhattan District Attorney has issued subpoenas to Delaware Life Insurance Co. and Clear Spring Life and Annuity Co. regarding their asset management practices. Affected employees are currently securing legal counsel to address the agency inquiries as the firm faces broad examination of its internal business operations.

Timeline

  1. In 2025, Mark Walter acquired the Buss family's Lakers stake.

  2. The Manhattan District Attorney's office issued subpoenas to Delaware Life and Clear Spring in June 2026.

  3. Mark Walter agreed to sell his Los Angeles Lakers stake in August 2026.

  4. The SEC requested interviews with Guggenheim staff in September 2026.

Market Landscape

The SEC's inquiry follows established regulatory precedents regarding the SEC's Investment Advisers Act fee disclosure requirements. This move marks an intensification of oversight into how private investment firms manage and report assets held within their affiliated insurance company portfolios.

Operators in the financial services sector should review their own internal policies regarding the documentation and disclosure of affiliated transactions. Ensure that compliance teams have mapped all inter-company lending to current regulatory thresholds to avoid potential investigative scrutiny.

The takeaway

The firm's asset divestment suggests a strategic pivot to shore up liquidity as federal and local investigations unfold. Leadership teams should prioritize auditing their own fee-disclosure and loan-classification logs to identify any misalignments with current reporting requirements.

Further reading

For more on how regulatory shifts impact firm operations, see Public Companies.

Live Poll

Do you trust that financial regulators are effectively overseeing the business practices of large investment firms?